Document is current
Any future updates will be listed below
-
Authors
Jacobs, Joshua S. https://orcid.org/0000-0001-7748-6887
Han, Joseph K.
Lee, Jason K.
Laidlaw, Tanya M.
Martin, Nicole L.
Caveney, Scott https://orcid.org/0000-0002-2006-5130
Ambrose, Christopher S. https://orcid.org/0000-0003-4175-7336
Martin, Neil
Spahn, Joseph D.
Hoyte, Flavia C. L. https://orcid.org/0000-0002-0426-6362
-
Funding
Funding for this research was provided by:
AstraZeneca
Amgen
- License Information
-
More Information
Article History
Received: 21 June 2024
Accepted: 18 September 2024
First Online: 8 November 2024
Declarations
:
: Joshua S. Jacobs has received fees for sponsored research, consultancy and speaking from AstraZeneca, Genentech, GSK, Regeneron Pharmaceuticals, and Teva Pharmaceuticals; Joseph K. Han has received consultancy fees from AstraZeneca, Genentech, Gossamer Bio, Novartis, Regeneron Pharmaceuticals, and Sanofi; Jason K. Lee has received research support from AstraZeneca, Genentech, GSK, Medexus, Novartis, Regeneron Pharmaceuticals, Roche, Sanofi, and Takeda; has received fees for speakers bureau from Aralez Bio, AstraZeneca, GSK, Medexus, Merck, Mylan, Novartis, and Sanofi; and receives consultancy fees from and is an advisory committee member of AstraZeneca, GSK, Medexus, Novartis, Regeneron Pharmaceuticals, and Sanofi; Tanya M. Laidlaw has served on scientific advisory boards for Eli Lilly, GSK, Regeneron Pharmaceuticals, and Sanofi; Nicole L. Martin, Christopher S. Ambrose, Neil Martin, and Joseph D. Spahn are employees of AstraZeneca and may own stock or stock options in AstraZeneca; Scott Caveney is an employee of Amgen and owns stock in Amgen; Flavia C. L. Hoyte has received honoraria from AstraZeneca, Genentech, Sanofi and Teva Pharmaceuticals; has participated in research with Genentech and Sanofi, for which her institution has been remunerated; and her family owns stock in Amgen.
: The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, International Council for Harmonisation Good Clinical Practice guidelines and applicable regulatory requirements. Approvals were obtained from the Copernicus Central Institutional Review Board (Cary, NC, USA), and local independent ethics committees. All patients or their guardians provided written informed consent in accordance with local requirements.
